APA (7th ed.) Citation

Heard, J., Vrinten, C., Schlander, M., Bellettato, C. M., van Lingen, C., Scarpa, M., . . . Weinhold, N. (2020). Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network. Orphanet Journal of Rare Diseases, 15(1), 1. https://doi.org/10.1186/s13023-019-1280-5

Chicago Style (17th ed.) Citation

Heard, Jean-Michel, et al. "Availability, Accessibility and Delivery to Patients of the 28 Orphan Medicines Approved by the European Medicine Agency for Hereditary Metabolic Diseases in the MetabERN Network." Orphanet Journal of Rare Diseases 15, no. 1 (2020): 1. https://doi.org/10.1186/s13023-019-1280-5.

MLA (9th ed.) Citation

Heard, Jean-Michel, et al. "Availability, Accessibility and Delivery to Patients of the 28 Orphan Medicines Approved by the European Medicine Agency for Hereditary Metabolic Diseases in the MetabERN Network." Orphanet Journal of Rare Diseases, vol. 15, no. 1, 2020, p. 1, https://doi.org/10.1186/s13023-019-1280-5.